e-learning
resources
Virtual 2021
06.09.2021
Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Delivery of anti-inflammatory and anti-oxidant synthetic mRNA to a rodent ARDS model by vibrating mesh nebulisation
S. McCarthy (Galway, Ireland), M. Angel (MA, United States of America), C. Rohde (MA, United States of America), C. Masterson (Galway, Ireland), R. Macloughlin (Galway, Ireland), J. Laffey (Galway, Ireland), D. O'Toole (Galway, Ireland)
Source:
Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Session:
Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Session type:
E-poster
Number:
2529
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. McCarthy (Galway, Ireland), M. Angel (MA, United States of America), C. Rohde (MA, United States of America), C. Masterson (Galway, Ireland), R. Macloughlin (Galway, Ireland), J. Laffey (Galway, Ireland), D. O'Toole (Galway, Ireland). Late Breaking Abstract - Delivery of anti-inflammatory and anti-oxidant synthetic mRNA to a rodent ARDS model by vibrating mesh nebulisation. 2529
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Delivery and efficacy of synthetic oligonucleotide vectors to an ARDS model by vibrating mesh nebulisation
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020
Late Breaking Abstract - Anti-inflammatory and anti-fibrotic effect of novel, pan-PDE inhibitors in human bronchial epithelial cells
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Year: 2020
Late Breaking Abstract - Enhancing the antimicrobial efficacy of mesenchymal stem cells (MSCs) to combat sepsis-induced acute lung injury (ALI) using a novel combination of immune-stimulants
Source: International Congress 2017 – Late-breaking findings in pulmonary diseases
Year: 2017
Late Breaking Abstract: Cathelicidin has direct anti-rhinoviral activity
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010
Late Breaking Abstract - Anti-inflammatory activity of novel transtilbene sulfonamide analogues as potential novel therapeutic agents for inflammatory lung disease
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Enhanced anti-inflammatory gene expression in humans following inhaled budesonide
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Late Breaking Abstract - Comparison of mesh and jet nebulizers with different interfaces in acute moderate to severe paediatric asthma
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma
Year: 2019
Immunomodulatory and antioxidant activity of vitamin A in the lung injury induced by wooden dust. Experimental studies
Source: Annual Congress 2007 - From environmental tobacco smoke and wood smoke at home to herbal tea at work
Year: 2007
Late Breaking Abstract - Regional lung heterogeneity during mechanical ventilation and gene expression in endotoxemia
Source: International Congress 2018 – New methods and concepts in exercise testing
Year: 2018
Late Breaking Abstract - External humidification does not alleviate human epithelial inflammation after CPAP therapy
Source: International Congress 2019 – Pathophysiological aspects of obstructive sleep apnoea from sea level to high altitude
Year: 2019
Late Breaking Abstract - The outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Late Breaking Abstract - Short exposure to moderate hyperoxia leads to long term effects in the murine lung in-vivo
Source: Virtual Congress 2021 – Paediatric lung disease: novel mechanisms, methods and translational studies
Year: 2021
Late Breaking Abstract - Biological phenotypes of ARDS show differential expression of genes involved in oxidative phosphorylation and immunomodulation: an illustration for the need of personalized medicine in ARDS.
Source: International Congress 2018 – Ventilation and lung imaging in critically ill patients
Year: 2018
Evaluation of antiinflammatory and antioxidant effect of mepenzolate in subacute cigarette exposure mouse model
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Late Breaking Abstract - Immunomodulatory protein ATYR1923 disrupts an in vitro model of sarcoid granuloma formation
Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Year: 2021
Late Breaking Abstract - ND-L02-s0201 treatment leads to efficacy in preclinical IPF models
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
N-acetylcysteine potentiates surfactant therapy for experimental meconium aspiration syndrome
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Late Breaking Abstract - Corticosteroid optimisation in severe asthma using composite biomarkers to adjust dose versus a symptom/risk-based algorithm
Source: Virtual Congress 2020 – ALERT: Asthma in adults and children
Year: 2020
Late Breaking Abstract - Generating iPSC derived alveolar macrophages as a novel model for respiratory research
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019
Nonsteroid anti-inflammatory agents depress inflammation-related respiratory disoders and hypoxia-induced mortality. Experimental model.
Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept